Peptides derived from the extracellular domain of the somatostatin receptor splicing variant SST5TMD4 increase malignancy in multiple cancer cell types

JUSTO PASTOR CASTAÑO FUENTESMANUEL DAVID GAHETE ORTIZEMILIA Mª ALORS PÉREZRAUL MIGUEL LUQUE HUERTAS2026-01-292026-01-29201910.1016/j.trsl.2019.02.0132-s2.0-85063523362https://www.scopus.com/inward/record.uri?eid=2-s2.https://ucocris.uco.es/handle/123456789/30210Biochemistry (medical)Physiology (medical)Public Health, Environmental and Occupational HealthPeptides derived from the extracellular domain of the somatostatin receptor splicing variant SST5TMD4 increase malignancy in multiple cancer cell typesresearch article